[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy]. / Neoadjuvante systemische therapie bij het primair operabel mammacarcinoom: meer voordelen dan alleen borstsparende behandeling.
Ned Tijdschr Geneeskd
; 152(46): 2519-25, 2008 Nov 15.
Article
em Nl
| MEDLINE
| ID: mdl-19055260
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
Nl
Ano de publicação:
2008
Tipo de documento:
Article